A novel CAR T-cell therapy designed to target cancerous tumours has shown promising early results in treating children with neuroblastoma.

The original pre-clinical work was funded by Neuroblastoma UK to help launch the study. Dr Karin Straathof, one of the lead investigators on the study, tells us more.